Quarterly labs are included with every BPC-157 plan through telos rx at telosrx.com, and they exist to give your provider ongoing information rather than a one-time check at intake. This article explains what to expect, why monitoring matters for a compounded peptide, and how it fits into your overall plan.
Quarterly labs are included in your plan at no extra cost and are arranged as part of ongoing care. Your provider uses them alongside what you report to decide whether to continue, adjust, or change your plan. There is no separate scheduling step required on your part.
Start your intake →Why monitoring matters for BPC-157
BPC-157 is compounded, not FDA-approved, and its published human evidence base is considerably thinner than that of long-established medications. Ongoing monitoring is one way a provider gathers real information about your specific situation rather than relying on general assumptions.
Quarterly labs give your provider objective data to work with alongside your own reports about how you are doing. Together these support a more informed decision than either source alone would provide.
Receiving BPC-157, and any adjustments to your plan, is subject to medical approval by a licensed provider. Monitoring is part of how that approval remains appropriate over time, not just at your initial intake.
What quarterly labs typically involve
Quarterly labs are arranged automatically as part of your plan, so you do not need to schedule them yourself or track when they are due. Your care team lets you know what is needed and when.
This article does not specify which exact labs apply to your situation, since that is a clinical decision your provider makes based on your history and plan. Ask your provider directly if you want to understand what your specific labs are checking for.
Labs are included in your plan at no additional cost, so there is no financial reason to skip or delay them.
Key takeaway: Quarterly labs are included, automatically arranged, and used alongside your own reports to guide your ongoing plan. They exist because a compounded peptide with a thinner evidence base benefits from continued attention, not a one-time review.
How labs and your own reports work together
Labs alone do not tell your provider everything. What you notice week to week, including anything unusual at an injection site or a change in how you feel, adds context that a lab result by itself cannot capture.
Keep a simple log between check-ins if you can. Specific notes, such as when something started or how it has changed, are more useful to your provider than a general impression offered at the last minute.
Bring this information to your quarterly check-in, or message your care team sooner if something feels significant enough not to wait for a scheduled review.
What happens after your labs come back
Your provider reviews your results alongside your reported experience. From there they decide whether to continue your current plan, make a dose adjustment, or recommend a different approach. Any of these outcomes is a normal part of ongoing care.
Dose adjustments are included in your plan at no separate cost. There is no financial disincentive built into raising a concern or having your provider recommend a change.
Start your intake to begin a plan that includes this kind of ongoing attention from the outset.
What if you have concerns between quarterly check-ins
You do not need to wait for your next scheduled labs to raise a concern. Unlimited messaging with your care team is included in your plan, and you can reach out anytime something feels off.
Message your care team about anything from a question about technique to a change you have noticed that concerns you. Your provider can decide whether it warrants earlier labs or simply a conversation.
Waiting until your next quarterly check-in is not required when something feels urgent or confusing. The asynchronous messaging system exists specifically to remove that wait.
Why this matters more for a compounded peptide
BPC-157 does not have the decades of large-scale study that long-established medications have. Because of that, ongoing monitoring plays a more central role in how your provider manages your care responsibly over time.
For general background on how lab testing is used in medical care broadly, see the NIH National Library of Medicine overview of lab tests. It does not address BPC-157 specifically but explains why monitoring is a standard part of medical care generally.
For background on how the FDA regulates the compounding process itself, see the FDA overview of drug compounding. It explains why individualized oversight, including labs, matters more for compounded medication than for a standardized product.
Staying consistent with your monitoring schedule
Missing a quarterly lab is not a crisis, but it does leave a gap in the information your provider has to work with. If you know you will be traveling or unavailable around a scheduled window, message your care team ahead of time to reschedule.
Treat quarterly labs the way you would treat any other routine part of your plan, worth keeping on the calendar rather than something to deprioritize when life gets busy. The information gathered protects the quality of your ongoing care.
If you consistently find scheduling difficult, tell your care team. They may be able to adjust timing or reminders to make it easier to stay consistent. Raising the issue is far more useful than quietly letting labs slip for months at a time.
Combining monitoring across multiple protocols
Some patients are also using other peptides such as sermorelin, PT-141, or NAD nasal spray. Mention this during intake so your provider has a complete picture when reviewing your labs and reports.
Monitoring across combined protocols is a decision your provider makes with your full history in view, not something to track separately for each peptide on your own.
Begin your evaluation and describe every protocol you are using or considering so your monitoring plan reflects your complete situation.
What to bring up during a quarterly check-in
Come prepared with specific details rather than a general sense of how things are going. Note any change in how you feel, how your injection sites have held up, and whether your routine has stayed consistent since your last check-in.
If your goals have shifted since you started, say so. A provider working from outdated goals cannot give you the most relevant guidance, and a quarterly check-in is a natural point to update that picture.
It is also a good moment to ask any questions you have been holding onto, whether about technique, storage, or what your results actually mean. There is no such thing as too small a question during this conversation.
How this differs from a one-time purchase model
Some sources selling compounded peptides treat the sale as the end of the relationship. They ship a product with no structured way to check in afterward. Quarterly labs and ongoing messaging represent a different model, one where the relationship continues after your first order ships.
This distinction matters more for a compounded peptide than it might for an over-the-counter product, since there is no standardized label telling you what to expect or watch for. Ongoing provider attention fills that gap instead.
When comparing options, ask directly whether monitoring is built into the plan or treated as a separate, optional add-on. The answer tells you a great deal about how seriously a provider takes ongoing care, and it is a fair question to ask before you commit to any source.
Understanding what monitoring can and cannot tell you
Labs and check-ins give your provider useful information, but they are not a guarantee that everything will go exactly as expected. They are a tool for catching issues early and adjusting your plan, not a promise about outcomes.
Be patient with the process. A single quarter of data is a starting point, not a complete picture. Your provider will generally want to see a consistent pattern over more than one check-in before drawing strong conclusions.
If you ever feel unsure about what your labs mean, ask your provider to explain them in plain terms. You are entitled to understand your own care, not just receive a result. A good provider will take the time to walk through what a result means and what, if anything, it changes about your plan.
Pricing and what is included
- Quarterly labs, included at no extra cost.
- Dose adjustments based on your labs and reports, included.
- Unlimited messaging with your care team between check-ins.
- Free 2-day shipping on your medication.
- Cancel anytime with no fee if your plan is not working for you.
BPC-157 through telos rx is priced as low as $116 per month, with all of the above included rather than billed separately as individual line items on top of the medication itself.
Frequently Asked Questions
Do I need to schedule my own quarterly labs?
No. Quarterly labs are arranged automatically as part of your plan, and your care team lets you know what is needed and when. There is no separate scheduling step required on your part.
Are quarterly labs an extra cost?
No. They are included in your plan at no additional charge, along with dose adjustments based on the results, so there is no financial reason to skip them.
What happens if my labs suggest a change is needed?
Your provider may recommend a dose adjustment or a different approach based on your labs and reported experience. This is a normal part of ongoing care and is included in your plan.
Can I contact my provider before my next scheduled labs?
Yes. Unlimited messaging with your care team is included, and you do not need to wait for a quarterly check-in to raise a concern that feels significant.
What if I miss a quarterly lab window?
Message your care team as soon as you know you will miss it so they can help you reschedule. It is not a crisis, but it does leave a gap in the information your provider has to work with.
Do labs apply the same way if I use more than one peptide?
Mention every protocol you are using during intake so your provider can build a monitoring plan around your complete situation, rather than treating each peptide separately.
telos rx is LegitScript-certified. Compounded medication is not FDA-approved and is prepared by partner compounding pharmacies. This article is general information, not medical advice, and does not replace guidance from your own provider. Approval is subject to medical approval by a licensed provider, and approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service.
Questions about labs or monitoring? Message the telos rx care team or start your evaluation at telos rx.